OTCMKTS:GNWSD StageZero Life Sciences (GNWSD) Stock Price, News & Analysis → America’s worst nightmare? (From Porter & Company) (Ad) Free GNWSD Stock Alerts $0.01 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share Today's Range$0.0128▼$0.012850-Day Range$0.01▼$0.0452-Week Range$0.17▼$0.89VolumeN/AAverage Volume4,987 shsMarket Capitalization$626,432.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get StageZero Life Sciences alerts: Email Address Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. About StageZero Life Sciences Stock (OTCMKTS:GNWSD)StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.Read More GNWSD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNWSD Stock News HeadlinesMay 2, 2024 | markets.businessinsider.comBuy Rating Affirmed: Wave Life Sciences’s Promising Future with Clinical Milestones and Strategic GSK PartnershipApril 29, 2024 | msn.comMany lessons on many levels at King's CollegeApril 3, 2024 | msn.comBuilding Equity Through Next Generation Science StandardsApril 1, 2024 | seekingalpha.comSZLS:CA StageZero Life Sciences Ltd.March 30, 2024 | msn.comSan Diego biotech news: Veteran life science execs raise $150M for cancer drug targeting hard-to-treat tumorsMarch 11, 2024 | bizjournals.comLA, Orange County life-science vacancy rate hits 3%February 27, 2024 | msn.com‘An extremely aggressive timeline’: Rhode Island Life Sciences Hub to hire inaugural CEO by MayFebruary 23, 2024 | bizjournals.comCommentary: Why Boston’s life sciences sector should fuel a new climatetech nicheFebruary 15, 2024 | yahoo.comLife Below Zero: Next Generation Season 2 Streaming: Watch & Stream Online via Disney PlusNovember 14, 2023 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USANovember 14, 2023 | finance.yahoo.comStageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USANovember 10, 2023 | news.yahoo.comReport: Utah’s life sciences industries are an economic juggernaut on the riseNovember 8, 2023 | benzinga.comUtah Ranks Among Fastest Growing Life Sciences Industries in the NationNovember 7, 2023 | finance.yahoo.comStageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer OfferingsOctober 26, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd flat on Thursday (SZLS)October 23, 2023 | msn.comGen Z Is Heading South For More Affordable HomesOctober 21, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd down on Friday (SZLS)October 20, 2023 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer OfferingsOctober 20, 2023 | finance.yahoo.comStageZero Life Sciences’ Clinical Business Introduces Third Pillar to Cancer OfferingsOctober 18, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd flat on Wednesday (SZLS)October 11, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd up on Wednesday (SZLS)October 7, 2023 | theglobeandmail.comClosing Bell: Stagezero Life Sciences Ltd flat on Friday (SZLS)September 6, 2023 | msn.comGeneone Life Science to raise 2.5 bln won via stock offeringJune 1, 2023 | bizjournals.comHere's how much Boston's life sciences industry has grown since 2018May 31, 2023 | msn.comMass. saw a 14.6 percent increase in life sciences jobs during pandemicSee More Headlines Receive GNWSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:GNWSD CUSIPN/A CIKN/A Webwww.stagezerolifesciences.com Phone(855) 420-7140FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,480,000.00 Net Margins217.39% Pretax MarginN/A Return on EquityN/A Return on Assets-61.21% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.06 Sales & Book Value Annual Sales$140,000.00 Price / Sales4.47 Cash FlowN/A Price / Cash FlowN/A Book Value($0.13) per share Price / Book-0.10Miscellaneous Outstanding Shares48,940,000Free FloatN/AMarket Cap$626,432.00 OptionableNot Optionable Beta2.97 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesJames R. Howard-TrippExecutive Chairman & Chief Executive OfficerRebecca GrecoHead-Investor RelationsKey CompetitorsSQZ BiotechnologiesNYSE:SQZSientraNASDAQ:SIENQMagna-LabOTCMKTS:MAGAAArgos TherapeuticsOTCMKTS:ARGSQHistogenNASDAQ:HSTOView All Competitors GNWSD Stock Analysis - Frequently Asked Questions How have GNWSD shares performed in 2024? StageZero Life Sciences' stock was trading at $0.0294 at the beginning of 2024. Since then, GNWSD shares have decreased by 56.5% and is now trading at $0.0128. View the best growth stocks for 2024 here. How do I buy shares of StageZero Life Sciences? Shares of GNWSD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:GNWSD) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
